Skip to main content

NU Skin Enterprises Inc (NUS)

Household and Personal Products Consumer Staples
Stock AI

Financial Metrics

Price to Earnings-1.09x
Revenue Growth (1Y)-15.44%
Debt to Equity0.39x

Strengths

Stock Chart

Valuation

NU Skin Enterprises Inc is undervalued

News

All
Press Releases
News
Filings
Nu Skin Enterprises Reports Second Quarter Results
August 10, 2026Nu Skin Enterprises Reports Second Quarter Results
Nu Skin Enterprises Announces Quarterly Dividend
August 10, 2026Nu Skin Enterprises Announces Quarterly Dividend
10-Q Quarterly Report for 2026 Q2
August 10, 202610-Q Quarterly Report for 2026 Q2
Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
July 21, 2026Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
10-Q Quarterly Report for 2026 Q1
May 08, 202610-Q Quarterly Report for 2026 Q1
Nu Skin Enterprises Reports First Quarter Results
May 07, 2026Nu Skin Enterprises Reports First Quarter Results
Nu Skin Enterprises Announces Quarterly Dividend
May 07, 2026Nu Skin Enterprises Announces Quarterly Dividend
Nu Skin Enterprises to Announce First Quarter 2026 Financial Results
April 13, 2026Nu Skin Enterprises to Announce First Quarter 2026 Financial Results
Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness
April 02, 2026Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness
Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer
March 20, 2026Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer
Nu Skin Appoints Chayce Clark as COO
March 09, 2026Nu Skin Appoints Chayce Clark as COO
Top 3 Defensive Stocks That May Rocket Higher In February
February 13, 2026Top 3 Defensive Stocks That May Rocket Higher In February
Nu Skin Stock Sinks After Weak Quarter, Soft Outlook
February 13, 2026Nu Skin Stock Sinks After Weak Quarter, Soft Outlook
10-K Annual Report for 2025 FY
February 13, 202610-K Annual Report for 2025 FY
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
February 12, 2026Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
Nu Skin Enterprises Announces Quarterly Dividend
February 12, 2026Nu Skin Enterprises Announces Quarterly Dividend
Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness
February 06, 2026Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness
Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results
January 14, 2026Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results
Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference
January 09, 2026Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference
Nu Skin Releases 2024 Social Impact and Sustainability Report
December 30, 2025Nu Skin Releases 2024 Social Impact and Sustainability Report
Nu Skin Unveils Prysm iO™: An Evolution in Intelligent Nutritional Wellness
December 18, 2025Nu Skin Unveils Prysm iO™: An Evolution in Intelligent Nutritional Wellness
10-Q Quarterly Report for 2025 Q3
November 07, 202510-Q Quarterly Report for 2025 Q3
Nu Skin Enterprises Reports Third Quarter Earnings
November 06, 2025Nu Skin Enterprises Reports Third Quarter Earnings
Nu Skin Enterprises Announces Quarterly Dividend
November 06, 2025Nu Skin Enterprises Announces Quarterly Dividend
Nu Skin Enterprises to Announce Third Quarter 2025 Financial Results
October 16, 2025Nu Skin Enterprises to Announce Third Quarter 2025 Financial Results
10-Q Quarterly Report for 2025 Q2
August 08, 202510-Q Quarterly Report for 2025 Q2
Nu Skin Enterprises Reports Second Quarter Revenue at High End of Guidance and Earnings Per Share Above Guidance
August 07, 2025Nu Skin Enterprises Reports Second Quarter Revenue at High End of Guidance and Earnings Per Share Above Guidance
Nu Skin Enterprises Announces Quarterly Dividend
August 07, 2025Nu Skin Enterprises Announces Quarterly Dividend
Nu Skin Enterprises to Announce Second Quarter 2025 Financial Results
July 10, 2025Nu Skin Enterprises to Announce Second Quarter 2025 Financial Results
Nu Skin Expands and Repackages ageLOC® Tru Face® Line, Setting a New Standard for Sustainable Skincare
June 25, 2025Nu Skin Expands and Repackages ageLOC® Tru Face® Line, Setting a New Standard for Sustainable Skincare
Nu Skin Enterprises Appoints James Winett to Board of Directors
June 02, 2025Nu Skin Enterprises Appoints James Winett to Board of Directors
10-Q Quarterly Report for 2025 Q1
May 09, 202510-Q Quarterly Report for 2025 Q1
Nu Skin Enterprises Announces Quarterly Dividend
May 08, 2025Nu Skin Enterprises Announces Quarterly Dividend
Nu Skin Enterprises Reports First Quarter Revenue at High End of Guidance
May 08, 2025Nu Skin Enterprises Reports First Quarter Revenue at High End of Guidance
Nu Skin Enterprises to Announce First Quarter 2025 Financial Results
April 02, 2025Nu Skin Enterprises to Announce First Quarter 2025 Financial Results
Nasdaq Surges Above 20,000; Crude Oil Moves Lower
February 14, 2025Nasdaq Surges Above 20,000; Crude Oil Moves Lower
Dow Falls 100 Points; US Industrial Output Increases In January
February 14, 2025Dow Falls 100 Points; US Industrial Output Increases In January
10-K Annual Report for 2024 FY
February 14, 202510-K Annual Report for 2024 FY
Nu Skin Enterprises Announces Quarterly Dividend
February 13, 2025Nu Skin Enterprises Announces Quarterly Dividend
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance
February 13, 2025Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance
Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance
January 13, 2025Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance
10-Q Quarterly Report for 2024 Q3
November 08, 202410-Q Quarterly Report for 2024 Q3
10-Q Quarterly Report for 2024 Q2
August 09, 202410-Q Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q1
May 09, 202410-Q Quarterly Report for 2024 Q1
10-K Annual Report for 2023 FY
February 15, 202410-K Annual Report for 2023 FY
10-Q Quarterly Report for 2023 Q3
November 02, 202310-Q Quarterly Report for 2023 Q3
10-Q Quarterly Report for 2023 Q2
August 02, 202310-Q Quarterly Report for 2023 Q2
10-Q Quarterly Report for 2023 Q1
May 04, 202310-Q Quarterly Report for 2023 Q1
10-K Annual Report for 2022 FY
February 16, 202310-K Annual Report for 2022 FY
10-Q Quarterly Report for 2022 Q3
November 03, 202210-Q Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q2
August 05, 202210-Q Quarterly Report for 2022 Q2
10-Q Quarterly Report for 2022 Q1
May 05, 202210-Q Quarterly Report for 2022 Q1
10-K Annual Report for 2021 FY
February 16, 202210-K Annual Report for 2021 FY
10-Q Quarterly Report for 2021 Q3
November 04, 202110-Q Quarterly Report for 2021 Q3

A. Company Overview

Nu Skin Enterprises, Inc. is a multinational company that specializes in the development and distribution of premium-quality beauty and wellness solutions. Operating in nearly 50 markets across the world, the company reported a revenue of $2.0 billion in 2023. The primary brands under Nu Skin include its beauty brand, Nu Skin; its wellness brand, Pharmanex; and its anti-aging brand, ageLOC. The company's business model revolves around direct selling, leveraging person-to-person marketing strategies that are complemented by social and digital platforms.

In addition to its core Nu Skin business, the company also engages in exploring synergistic and adjacent growth opportunities through an independent business entity known as Rhyz Inc., which encompasses a variety of consumer, technology, and manufacturing companies. For 2023, Rhyz contributed approximately $216.6 million, representing 11% of the total revenue, playing a crucial role in diversifying the company’s revenue sources.

B. Revenue Streams

Nu Skin generates its revenue from a mix of domestic and international operations, with approximately 26% coming from the United States. The remaining revenue is derived from various international markets, which may be subject to fluctuations due to foreign currency exchange rates. The company’s sales strategies and results can also be influenced by broader global economic, political, and demographic trends.

C. Product Portfolio

Nu Skin’s product portfolio is structured into two main categories: beauty products and wellness products, both of which focus on innovation and premium quality. Under the Nu Skin and Pharmanex brands, the company offers a diverse range of products, including skincare devices, cosmetics, nutritional supplements, and anti-aging solutions.

Product Categories

  • Beauty Products: The beauty segment emphasizes innovative skin care devices, cosmetics, and personal care products. The top-selling items in this category include the ageLOC LumiSpa devices and Nutricentials skin care products. A significant portion of the beauty product revenue is driven by ageLOC products, which accounted for 46% of the beauty category revenue and 20% of total revenue in 2023.
  • Wellness Products: Similarly, the wellness category focuses on developing nutritional supplements that are scientifically substantiated. Popular products include the ageLOC TR90 weight management system and various LifePak nutritional supplements. AgeLOC wellness products accounted for 46% of the wellness category revenue, contributing to 21% of total revenue in 2023.

Product Development

Innovation is a cornerstone of Nu Skin's approach. The company invests heavily in research and product development, collaborating with third-party institutions and maintaining facilities in the United States and Mainland China. This involves leveraging cutting-edge technologies and conducting clinical studies to substantiate product claims. Ongoing projects include next-generation skincare items and nutritional supplements.

Intellectual Property

Nu Skin protects its products and brand identity through a robust intellectual property (IP) strategy. The company holds numerous registered trademarks, such as Nu Skin®, Pharmanex®, and ageLOC®. Additionally, many of its products and devices are based on proprietary technologies and may include patent protections, trade secrets, and licensing agreements.

D. Sourcing and Production

Nu Skin primarily sources its products from trusted third-party suppliers and its own manufacturing subsidiaries. Approximately 23% of products are produced internally, particularly in Mainland China, where the majority of domestic sales are fulfilled. The sourcing strategy allows the company to maintain consistency in product quality while enabling quicker response times to market demands.

E. Distribution Channel

The company employs a direct selling model that capitalizes on person-to-person marketing. This model has evolved, increasingly integrating aspects of social commerce and digital marketing, especially in the wake of the COVID-19 pandemic, which accelerated a shift toward online shopping. The current distribution strategies emphasize empowering the sales force to leverage digital tools for enhancing customer engagement.

Consumer Group and Sales Network

Nu Skin delineates its distribution channel into two main segments:

  • Consumer Group: Comprised of individuals purchasing products primarily for personal use, who may also share experiences with friends and family.
  • Sales Network: Consists of Brand Affiliates who buy, resell products, and recruit new consumers or sellers.

Sales Incentives

The company actively engages its sales force through recognition programs and incentive trips aimed at motivating high performance and team cohesion. Regular training events further enhance sales capabilities and product knowledge across global teams.

F. Geographic Markets

Nu Skin operates in several key geographic regions, each with distinct market characteristics. The company segments its international operations into multiple categories, including Mainland China, South Korea, Southeast Asia/Pacific, Americas, Japan, Hong Kong/Taiwan, and Europe & Africa, each contributing uniquely to the overall revenue. The diversity in market demographics and regulatory environments necessitates customized marketing and sales strategies specific to each region.

G. Regulatory Environment

Nu Skin's operations are subject to a complex array of regulations governing direct selling practices and the classification of products across various jurisdictions. This includes compliance with local laws that can vary significantly, especially in regions like Mainland China, where direct selling is tightly regulated.

Direct Selling Regulations

Direct selling is policed by national and local government entities to prevent fraudulent practices, such as pyramid schemes. Nu Skin maintains a compliance framework designed to adhere to these regulations and protect both consumers and the sales force.

Product Regulations

Regulatory bodies, such as the FDA in the United States, oversee beauty and wellness product claims, requiring substantial substantiation for marketing materials. The global nature of Nu Skin’s business means navigating different regulatory landscapes that dictate the types of products offered and claims made.

H. Competition

Nu Skin faces significant competition within the direct selling sector from established companies that possess greater financial resources and market share. The competitive landscape includes both direct selling firms and traditional retail brands, necessitating innovative product offerings and effective customer engagement strategies to maintain a market presence.

Stock Infos

SectorConsumer Staples
IndustryHousehold and Personal Products
CEORyan S. Napierski

Dividends

Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.